The frequency of Pap smear screening in the United States
- PMID: 15009779
- PMCID: PMC1492158
- DOI: 10.1111/j.1525-1497.2004.21107.x
The frequency of Pap smear screening in the United States
Abstract
Background: U.S. professional medical societies and the national health systems of all other industrialized nations recommend that most women need not undergo Papanicolaou (Pap) smear screening annually. There are no data, however, regarding the frequency at which women actually undergo screening.
Objective: To describe the frequency of cervical cancer screening in the United States.
Design: National Health Interview Survey, a cross-sectional population-based telephone survey conducted by the National Center for Health Statistics.
Participants: Representative sample of U.S. women age 21 and older who denied a history of cancer (N = 16,467).
Measurements: Pap smear screening frequency, categorized as no regular screening or screening at 1 of 3 discrete screening intervals (every year, every 2 years, or every 3 years) based on each woman's reported number of Pap smears in the previous 6 years.
Results: The vast majority (93%) of American women report having had at least one Pap smear in their lifetime. Among women with no history of abnormal smears, 55% undergo Pap smear screening annually, 17% report a 2-year screening interval, 16% report being screened every 3 years, and 11% are not being screened regularly. Even the very elderly report frequent screening-38% of women age 75 to 84 and 20% of women age 85 and older reported annual Pap smears. Overall, 20% of women reported having had at least one abnormal Pap smear. Among these women, rates of frequent Pap smear screening are considerably higher-80% undergo annual screening, with only a modest decline in screening frequency with increasing age.
Conclusions: The majority of American women report being screened for cervical cancer more frequently than recommended. Lengthening the screening interval would not only reduce the volume of specimens that cytotechnologists are required to read, but would also reduce the follow-up testing after abnormal smears.
Figures




Similar articles
-
Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.BMC Cancer. 2010 Jun 21;10:310. doi: 10.1186/1471-2407-10-310. BMC Cancer. 2010. PMID: 20565935 Free PMC article.
-
Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.Reprod Health. 2021 Jun 30;18(1):138. doi: 10.1186/s12978-021-01188-7. Reprod Health. 2021. PMID: 34193195 Free PMC article.
-
Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.Int J Epidemiol. 1995 Jun;24(3):493-8. doi: 10.1093/ije/24.3.493. Int J Epidemiol. 1995. PMID: 7672887
-
What rate of Iranian women perform Pap smear test? Results from a meta-analysis.Prev Med. 2024 Mar;180:107871. doi: 10.1016/j.ypmed.2024.107871. Epub 2024 Jan 21. Prev Med. 2024. PMID: 38262561 Review.
-
Access to pap smear among black women compared to other racial/ethnic groups: a systematic review with meta-analysis.Cien Saude Colet. 2025 Mar;30(3):e01852023. doi: 10.1590/1413-81232025303.01852023. Epub 2024 Jan 20. Cien Saude Colet. 2025. PMID: 40266043
Cited by
-
Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005-2014.Papillomavirus Res. 2018 Dec;6:52-57. doi: 10.1016/j.pvr.2018.10.002. Epub 2018 Oct 25. Papillomavirus Res. 2018. PMID: 30420338 Free PMC article.
-
Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.Pharmacoeconomics. 2005;23(11):1107-22. doi: 10.2165/00019053-200523110-00004. Pharmacoeconomics. 2005. PMID: 16277547 Review.
-
Molecular Genetic Study to Detect Prevalence of High-risk Human Papilloma Virus Strains (type 16 and 18) in Cervical Lesions and Asymptomatic Healthy Subjects of Rural Central India.J Cytol. 2019 Jan-Mar;36(1):32-37. doi: 10.4103/JOC.JOC_10_18. J Cytol. 2019. PMID: 30745737 Free PMC article.
-
What Australian women want and when they want it: cervical screening testing preferences, decision-making styles and information needs.Health Expect. 2013 Jun;16(2):177-88. doi: 10.1111/j.1369-7625.2011.00707.x. Epub 2011 Jul 4. Health Expect. 2013. PMID: 21726363 Free PMC article.
-
Multiple-type human papillomavirus infection in male anogenital sites: prevalence and associated factors.Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1077-83. doi: 10.1158/1055-9965.EPI-08-0447. Epub 2009 Mar 24. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19318438 Free PMC article.
References
-
- Frame PS, Frame JS. Determinants of cancer screening frequency: the example of screening for cervical cancer. J Am Board Fam Pract. 1998;11:87–95. - PubMed
-
- Fahs MC, Mandelblatt J, Schecter C, Muller C. Cost effectiveness of cervical cancer screening for the elderly. Ann Intern Med. 1992;117:520–7. - PubMed
-
- American College of Physicians. Guidelines: screening for cervical cancer. In: Eddy DM, editor. Common Screening Tests. Philadelphia, Pa: American College of Physicians; 1991. pp. 413–4.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials